TrialLancet (London, England)2015

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.

Anita Kohli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.